cAMP‐Induced Expression of the Orphan Nuclear Receptor Nur77 in MA‐10 Leydig Cells Involves a CaMKI Pathway
- 4 March 2009
- journal article
- research article
- Published by Wiley in Journal of Andrology
- Vol. 30 (2), 134-145
- https://doi.org/10.2164/jandrol.108.006387
Abstract
The Nur77(Nr4a1) gene, encoding the orphan nuclear receptor NUR77 (NR4A1), is an immediate early response gene whose expression is rapidly induced by a variety of physiologic stimuli. Nur77 is expressed in several organs, including the classic steroidogenic tissues: gonads and adrenal. In MA-10 Leydig cells, NUR77 has been shown to regulate expression of several genes involved in steroidogenesis and male sex differentiation. In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the adenylate cyclase/cyclic adenosine monophosphate (CAMP) signaling pathway. Even though Nur77 expression is induced both at the mRNA and protein levels in response to LH/forskolin/cAMP in Leydig cells, the mechanisms involved remain largely unknown. Here, we report that cAMP-mediated induction of Nur77 expression at the protein, mRNA, and promoter levels in MA-10 cells involves different mechanisms. We found that increased NUR77 protein requires transcription and translation, whereas increased Nur77 mRNA does not require de novo protein synthesis, and would therefore rely on transcription factors already present in the cell. In addition, our detailed analysis of the Nur77 promoter in MA-10 cells revealed that distinct regulatory elements are involved in basal and cAMP-induced Nur77 transcription. Finally, we found that maximal cAMP-mediated increase in Nur77 promoter activity involves a Ca2+/calmodulin kinase (CaMK)-dependent pathway and that Ca2+/calmodulin kinase I regulates Nur77 promoter activity in Leydig cells. Thus, our findings demonstrate the involvement of various mechanisms in the regulation of Nur77 expression in MA-10 Leydig cells, including a previously uncharacterized CaMK pathway.This publication has 47 references indexed in Scilit:
- The Orphan Nuclear Receptor NUR77 Regulates Hormone-Induced StAR Transcription in Leydig Cells through Cooperation with Ca2+/Calmodulin-Dependent Protein Kinase IMolecular Endocrinology, 2008
- Regulation of NGFI‐B/Nur77 gene expression in the rat ovary and in leydig tumor cells MA‐10Molecular Reproduction and Development, 2007
- The Orphan Nuclear Receptor NR4A1 Regulates Insulin-Like 3 Gene Transcription in Leydig Cells1Biology of Reproduction, 2006
- Role of Nuclear Receptors in INSL3 Gene Transcription in Leydig CellsAnnals of the New York Academy of Sciences, 2005
- The Human 3β-Hydroxysteroid Dehydrogenase/Δ5-Δ4 Isomerase Type 2 Promoter Is a Novel Target for the Immediate Early Orphan Nuclear Receptor Nur77 in Steroidogenic CellsEndocrinology, 2005
- The Orphan Nuclear Receptor NGFIB Regulates Transcription of 3β-Hydroxysteroid DehydrogenaseOnline Journal of Public Health Informatics, 2004
- Regulation of Axonal Extension and Growth Cone Motility by Calmodulin-Dependent Protein Kinase IJournal of Neuroscience, 2004
- The Orphan Nuclear Receptors NURR1 and NGFIB Regulate Adrenal Aldosterone ProductionMolecular Endocrinology, 2004
- Regulation of NGFI-B expression during the ovulatory processMolecular and Cellular Endocrinology, 2003
- Regulation of the Nuclear Orphan Receptor Nur77 in Bone by Parathyroid HormoneBiochemical and Biophysical Research Communications, 2001